These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 14748411)

  • 1. Association between droperidol use and sudden death in two patients intoxicated with illicit stimulant drugs.
    Cox RD; Koelliker DE; Bradley KG
    Vet Hum Toxicol; 2004 Feb; 46(1):21-3. PubMed ID: 14748411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of the safety and efficacy of droperidol for the rapid sedation of severely agitated and violent patients.
    Shale JH; Shale CM; Mastin WD
    J Clin Psychiatry; 2003 May; 64(5):500-5. PubMed ID: 12755651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized clinical trial comparing intravenous midazolam and droperidol for sedation of the acutely agitated patient in the emergency department.
    Knott JC; Taylor DM; Castle DJ
    Ann Emerg Med; 2006 Jan; 47(1):61-7. PubMed ID: 16387219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of acute undifferentiated agitation in the emergency department: a randomized double-blind trial of droperidol, ziprasidone, and midazolam.
    Martel M; Sterzinger A; Miner J; Clinton J; Biros M
    Acad Emerg Med; 2005 Dec; 12(12):1167-72. PubMed ID: 16282517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discontinuation of droperidol for the control of acutely agitated out-of-hospital patients.
    Martel M; Miner J; Fringer R; Sufka K; Miamen A; Ho J; Clinton J; Biros M
    Prehosp Emerg Care; 2005; 9(1):44-8. PubMed ID: 16036827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parenteral Antipsychotic Choice and Its Association With Emergency Department Length of Stay for Acute Agitation Secondary to Alcohol Intoxication.
    Cole JB; Klein LR; Martel ML
    Acad Emerg Med; 2019 Jan; 26(1):79-84. PubMed ID: 29851193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of droperidol in behavioural emergencies.
    Shale JH; Shale CM; Mastin WD
    Expert Opin Drug Saf; 2004 Jul; 3(4):369-78. PubMed ID: 15268653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical restraint for the agitated patient in the emergency department: lorazepam versus droperidol.
    Richards JR; Derlet RW; Duncan DR
    J Emerg Med; 1998; 16(4):567-73. PubMed ID: 9696171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Droperidol: efficacy and side effects in psychiatric emergencies.
    Chambers RA; Druss BG
    J Clin Psychiatry; 1999 Oct; 60(10):664-7. PubMed ID: 10549682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naturalistic study of intramuscular ziprasidone versus conventional agents in agitated elderly patients: retrospective findings from a psychiatric emergency service.
    Kohen I; Preval H; Southard R; Francis A
    Am J Geriatr Pharmacother; 2005 Dec; 3(4):240-5. PubMed ID: 16503319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of high-dose droperidol in agitated patients.
    Szuba MP; Bergman KS; Baxter LR; Guze BH; Reynolds CA; Pelletier LR
    J Clin Psychopharmacol; 1992 Apr; 12(2):144-6. PubMed ID: 1573042
    [No Abstract]   [Full Text] [Related]  

  • 12. Droperidol in the emergency department: is it safe?
    Richards JR; Schneir AB
    J Emerg Med; 2003 May; 24(4):441-7. PubMed ID: 12745049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acutely agitated patients: a comparison of the use of haloperidol and droperidol in the emergency department.
    Glow SD
    J Emerg Nurs; 1997 Dec; 23(6):626-8. PubMed ID: 9460404
    [No Abstract]   [Full Text] [Related]  

  • 14. Structured team approach to the agitated patient in the emergency department.
    Downes MA; Healy P; Page CB; Bryant JL; Isbister GK
    Emerg Med Australas; 2009 Jun; 21(3):196-202. PubMed ID: 19527279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of droperidol and haloperidol for use by paramedics: assessment of safety and effectiveness.
    Macht M; Mull AC; McVaney KE; Caruso EH; Johnston JB; Gaither JB; Shupp AM; Marquez KD; Haukoos JS; Colwell CB
    Prehosp Emerg Care; 2014; 18(3):375-80. PubMed ID: 24460451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Droperidol use in the emergency department is not safe.
    Prosser RL
    Acad Emerg Med; 2006 May; 13(5):585-6; author reply 586-7. PubMed ID: 16641482
    [No Abstract]   [Full Text] [Related]  

  • 17. The management of severe emergence agitation using droperidol.
    Hatzakorzian R; Shan WL; Côté AV; Schricker T; Backman SB
    Anaesthesia; 2006 Nov; 61(11):1112-5. PubMed ID: 17042853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological management of the agitated pediatric patient.
    Adimando AJ; Poncin YB; Baum CR
    Pediatr Emerg Care; 2010 Nov; 26(11):856-60; quiz 861-3. PubMed ID: 21057285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of intravenous droperidol in the prehospital setting.
    Rosen CL; Ratliff AF; Wolfe RE; Branney SW; Roe EJ; Pons PT
    J Emerg Med; 1997; 15(1):13-7. PubMed ID: 9017481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ziprasidone for sedation of the agitated ED patient.
    Martel ML
    Am J Emerg Med; 2004 May; 22(3):238. PubMed ID: 15138973
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.